SG Americas Securities’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,636
| Closed | -$126K | – | 2625 |
|
|
2025
Q1 | $126K | Sell |
16,636
-6,565
| -28% | -$49.7K | ﹤0.01% | 2554 |
|
|
2024
Q4 | $283K | Buy |
23,201
+8,144
| +54% | +$99.3K | ﹤0.01% | 1621 |
|
|
2024
Q3 | $252K | Sell |
15,057
-70,115
| -82% | -$1.17M | ﹤0.01% | 2034 |
|
|
2024
Q2 | $1.49M | Buy |
85,172
+75,236
| +757% | +$1.31M | 0.01% | 1025 |
|
|
2024
Q1 | $169K | Sell |
9,936
-4,513
| -31% | -$76.8K | ﹤0.01% | 1865 |
|
|
2023
Q4 | $147K | Buy |
14,449
+1,587
| +12% | +$16.1K | ﹤0.01% | 2220 |
|
|
2023
Q3 | $116K | Buy |
+12,862
| New | +$116K | ﹤0.01% | 2441 |
|
|
2023
Q2 | – | Sell |
-11,066
| Closed | -$113K | – | 2079 |
|
|
2023
Q1 | $113K | Sell |
11,066
-1,071
| -9% | -$10.9K | ﹤0.01% | 2587 |
|
|
2022
Q4 | $128K | Buy |
12,137
+949
| +8% | +$10K | ﹤0.01% | 2306 |
|
|
2022
Q3 | $143K | Sell |
11,188
-1,420
| -11% | -$18.2K | ﹤0.01% | 2300 |
|
|
2022
Q2 | $162K | Buy |
+12,608
| New | +$162K | ﹤0.01% | 2558 |
|
|
2022
Q1 | – | Sell |
-10,916
| Closed | -$168K | – | 2634 |
|
|
2021
Q4 | $168K | Sell |
10,916
-4,947
| -31% | -$76.1K | ﹤0.01% | 2489 |
|
|
2021
Q3 | $358K | Buy |
+15,863
| New | +$358K | ﹤0.01% | 2561 |
|